| CTRI Number |
CTRI/2025/07/089966 [Registered on: 02/07/2025] Trial Registered Prospectively |
| Last Modified On: |
27/06/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Behavioral |
| Study Design |
Cluster Randomized Trial |
|
Public Title of Study
|
Impact of School and Home-Based Strategies in Reducing Screen Time Among Pre-school Children |
|
Scientific Title of Study
|
Impact of School and Home-Based Strategies in Reducing Screen Time Among Pre-school Children: A Clustered Randomized Controlled Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Anshu Singh |
| Designation |
Resident Doctor |
| Affiliation |
Government Medical College, Akola |
| Address |
Department of Community Medicine, Government Medical College, Akola
Akola MAHARASHTRA 444001 India |
| Phone |
9341093471 |
| Fax |
|
| Email |
doctoranshusingh@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Umesh Kawalkar |
| Designation |
Assistant Professor |
| Affiliation |
Government Medical College, Akola |
| Address |
Department of Community Medicine, Government Medical College, Akola
Akola MAHARASHTRA 444001 India |
| Phone |
9730196442 |
| Fax |
|
| Email |
umeshkawalkar01@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Anshu Singh |
| Designation |
Resident Doctor |
| Affiliation |
Government Medical College, Akola |
| Address |
Department of Community Medicine, Government Medical College, Akola
Akola MAHARASHTRA 444001 India |
| Phone |
9341093471 |
| Fax |
|
| Email |
doctoranshusingh@gmail.com |
|
|
Source of Monetary or Material Support
|
| Government Medical College, Akola Maharashtra India 444001 |
|
|
Primary Sponsor
|
| Name |
Dr Anshu Singh |
| Address |
Department of Community Medicine, Government Medical College, Akola, Maharashtra, India-444001 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Anshu Singh |
Government Medical College, Akola |
Room no.2 Department of Community Medicine, Government Medical College, Akola 444001 Akola MAHARASHTRA |
9341093471
doctoranshusingh@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Government Medical College, Akola |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Screentime among Childrens |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Health Education |
Educational Module for 3 Months brainstorming sessions with seminars will be conducted |
| Comparator Agent |
Health educational module without session |
Educational module without brainstorming session |
|
|
Inclusion Criteria
|
| Age From |
3.00 Year(s) |
| Age To |
6.00 Year(s) |
| Gender |
Both |
| Details |
Schools willing to participate in the study.
Children aged 3-6 years and their parental/guardian assent for participation.
Parent and teachers those giving consent for the study. |
|
| ExclusionCriteria |
| Details |
Children with developmental delays affecting screen time behaviours.
Parents and school not willing to comply with follow-up requirements. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Reduction in daily screen time (minutes per day) measured via parental self-report and a validated screen time log diary. |
Reduction in daily screen time (30-minutes per day) |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Behavioural changes in children |
Attention span,
Social interactions,
Engagement in non-screen activities will be assessed at baseline & every four weeks |
|
|
Target Sample Size
|
Total Sample Size="300" Sample Size from India="300"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This three-arm cluster randomized controlled trial aims to evaluate the effectiveness of school-based and parent-based interventions in reducing daily screen time among 3–6-year-old preschool children in Akola city, Maharashtra. A total of 12 pre-primary schools will be randomly allocated to one of three groups: (1) Control group (no intervention other than educational module), (2) School Recommendations + Teacher Education, and (3) Parent Education via structured modules and workshops. The study will measure changes in daily screen exposure (primary outcome) and behavioural parameters such as attention span, social interaction, sleep patterns, and engagement in non-screen activities (secondary outcomes) at baseline, 3 months, and 6 months. The sample size is 300 children (100 per arm), accounting for clustering effects. The trial includes capacity-building for teachers and awareness modules for parents, and it seeks to generate evidence-based strategies for promoting healthier screen habits in early childhood. Data will be analyzed using mixed-effect regression models and intention-to-treat analysis. |